BioCentury
ARTICLE | Clinical News

Rixubis regulatory update

September 22, 2014 7:00 AM UTC

FDA approved an sBLA from Baxter for Rixubis to control and prevent bleeding episodes, for perioperative management and for routine prophylactic use in children with hemophilia B. Last year, FDA appro...